Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

HJ Whitaker, RSM Tsang, R Byford, NJ Andrews… - Journal of Infection, 2022 - Elsevier
Background COVID-19 vaccines approved in the UK are highly effective in general
population cohorts, however, data on effectiveness amongst individuals with clinical …

The clinical information systems response to the COVID-19 pandemic

JJ Reeves, NM Pageler, EC Wick… - Yearbook of medical …, 2021 - thieme-connect.com
Objective: The year 2020 was predominated by the coronavirus disease 2019 (COVID-19)
pandemic. The objective of this article is to review the areas in which clinical information …

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised …

CC Butler, J Dorward, LM Yu, O Gbinigie, G Hayward… - The Lancet, 2021 - thelancet.com
Background Azithromycin, an antibiotic with potential antiviral and anti-inflammatory
properties, has been used to treat COVID-19, but evidence from community randomised …

A systematic scoping review of digital health technologies during COVID-19: a new normal in primary health care delivery

C Ndayishimiye, H Lopes, J Middleton - Health and Technology, 2023 - Springer
This scoping review compiled information concerning digital health technologies (DHTs)
evolution to support primary health care (PHC) during COVID-19 and lessons for the future …

Association between blood pressure control and coronavirus disease 2019 outcomes in 45 418 symptomatic patients with hypertension: an observational cohort study

JP Sheppard, BD Nicholson, J Lee, D McGagh… - …, 2021 - Am Heart Assoc
Hypertension has been identified as a risk factor for coronavirus disease 2019 (COVID-19)
and associated adverse outcomes. This study examined the association between …

LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK

M Sivan, T Greenhalgh, JL Darbyshire, G Mir… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Long COVID, a new condition whose origins and natural history are not yet fully
established, currently affects 1.5 million people in the UK. Most do not have access to …

[HTML][HTML] Representativeness, vaccination uptake, and COVID-19 clinical outcomes 2020-2021 in the UK Oxford-Royal College of general practitioners research and …

M Leston, WH Elson, C Watson… - JMIR Public Health …, 2022 - publichealth.jmir.org
Background: The Oxford-Royal College of General Practitioners (RCGP) Research and
Surveillance Centre (RSC) is one of Europe's oldest sentinel systems, working with the UK …

Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from …

BD Nicholson, JM Ordóñez-Mena, S Lay-Flurrie… - British journal of …, 2022 - nature.com
Background It remains unclear to what extent reductions in urgent referrals for suspected
cancer during the COVID-19 pandemic were the result of fewer patients attending primary …

[HTML][HTML] COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care …

HJ Whitaker, RSM Tsang, R Byford, C Aspden… - Journal of Infection, 2023 - Elsevier
Background COVID-19 vaccines have been shown to be highly effective against
hospitalisation and death following COVID-19 infection. COVID-19 vaccine effectiveness …

[HTML][HTML] Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons …

J Bagaria, T Jansen, DFP Marques… - …, 2022 - eurosurveillance.org
As the COVID-19 pandemic began in early 2020, primary care influenza sentinel
surveillance networks within the Influenza-Monitoring Vaccine Effectiveness in Europe (I …